IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

LOBEFARO, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.366
NA - Nord America 1.298
AS - Asia 1.163
SA - Sud America 122
Continente sconosciuto - Info sul continente non disponibili 81
AF - Africa 25
OC - Oceania 3
Totale 4.058
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.229
DE - Germania 710
SG - Singapore 330
CN - Cina 310
IT - Italia 282
BD - Bangladesh 156
HK - Hong Kong 136
BR - Brasile 98
VN - Vietnam 68
RU - Federazione Russa 61
SE - Svezia 60
GB - Regno Unito 58
IN - India 55
NL - Olanda 50
FR - Francia 48
CA - Canada 41
FI - Finlandia 31
IE - Irlanda 22
JP - Giappone 18
ID - Indonesia 16
CI - Costa d'Avorio 14
TR - Turchia 14
UA - Ucraina 9
DK - Danimarca 8
KR - Corea 8
PH - Filippine 8
MX - Messico 7
AR - Argentina 6
BE - Belgio 6
PL - Polonia 6
IQ - Iraq 5
PK - Pakistan 5
SA - Arabia Saudita 5
JM - Giamaica 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
BO - Bolivia 3
CH - Svizzera 3
CO - Colombia 3
CR - Costa Rica 3
EC - Ecuador 3
ES - Italia 3
JO - Giordania 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
TT - Trinidad e Tobago 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BH - Bahrain 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
IR - Iran 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.978
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 660
Ashburn 207
Singapore 159
Hong Kong 121
San Jose 92
Chandler 80
Dallas 76
Milan 60
Council Bluffs 50
Hefei 45
New York 43
Beijing 41
Santa Clara 40
Los Angeles 32
Ho Chi Minh City 26
Bengaluru 24
Dublin 22
Southend 22
Helsinki 19
Munich 19
Guangzhou 18
Buffalo 17
Boardman 16
Atlanta 15
Abidjan 14
Hanoi 14
Lauterbourg 14
Moscow 14
Princeton 13
São Paulo 13
Tokyo 13
Wilmington 12
Fairfield 11
Nuremberg 11
Shanghai 11
Naples 10
Cangzhou 9
Istanbul 9
Jakarta 9
Ottawa 9
Turin 9
Cambridge 8
Hyderabad 8
Nanjing 8
Phoenix 8
Seattle 8
Lafayette 7
London 7
Montreal 7
Monza 7
Salt Lake City 7
Toronto 7
Turku 7
Ann Arbor 6
Brussels 6
Da Nang 6
Düsseldorf 6
Fuzhou 6
Rome 6
Seoul 6
Woodbridge 6
Bologna 5
Dearborn 5
Houston 5
Lappeenranta 5
Pessac 5
Pune 5
Rho 5
Shenyang 5
Warsaw 5
Augusta 4
Bochum 4
Brooklyn 4
Charlotte 4
Hillsboro 4
Manchester 4
McAllen 4
Padua 4
Philadelphia 4
Stockholm 4
Voghera 4
Amman 3
Barnet 3
Bridgetown 3
Changsha 3
Chicago 3
Columbus 3
Delhi 3
Denver 3
Eitensheim 3
Fortaleza 3
Hangzhou 3
Islamabad 3
Jinan 3
Las Vegas 3
Memphis 3
Milwaukee 3
Nanchang 3
New Delhi 3
Parma 3
Totale 2.382
Salva come PNG Salva come JPEG
Nome #
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 456
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State 351
The landscape of actionable gene fusions in colorectal cancer 286
Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape 252
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma : Myth or Reality? 252
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial 237
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 235
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 205
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab 199
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 192
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 186
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 185
Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors 183
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology 176
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers 168
Oral Capecitabine-Vinorelbine is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer 131
The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis 127
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis 126
Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications 111
Totale 4.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.449
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202276 0 2 4 2 2 3 0 7 8 13 1 34
2022/2023264 26 26 22 26 21 51 5 27 24 6 23 7
2023/2024638 21 10 11 8 45 49 101 77 43 79 105 89
2024/2025948 80 86 84 98 47 36 67 62 62 96 74 156
2025/20261.608 175 139 166 109 104 67 199 48 132 110 195 164
2026/2027380 119 261 0 0 0 0 0 0 0 0 0 0
Totale 4.058